Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Oct;264(2):132-147.
doi: 10.1002/path.6319. Epub 2024 Jul 29.

Nerve growth factor inducible (VGF) is a secreted mediator for metastatic breast cancer tropism to the brain

Rita Carvalho  1   2   3 , Liliana Santos  4   5   6 , Inês Conde  1   2   3 , Ricardo Leitão  4   5   6 , Hugo Rs Ferreira  4   5   6 , Célia Gomes  4   5   6 , Ana Paula Silva  4   5   6 , Fernando Schmitt  2   7   8 , Carina Carvalho-Maia  9 , João Lobo  3   9   10 , Carmen Jerónimo  9   10 , Joana Paredes  1   2   8 , Ana Sofia Ribeiro  1   2
Affiliations

Nerve growth factor inducible (VGF) is a secreted mediator for metastatic breast cancer tropism to the brain

Rita Carvalho et al. J Pathol. 2024 Oct.

Abstract

Brain metastases are one of the most serious clinical problems in breast cancer (BC) progression, associated with lower survival rates and a lack of effective therapies. Thus, to dissect the early stages of the brain metastatic process, we studied the impact of brain organotropic BC cells' secretomes on the establishment of the brain pre-metastatic niche (PMN). We found that BC cells with specific tropism to the brain caused significant blood-brain barrier (BBB) disruption, as well as microglial activation, in both in vitro and in vivo models. Further, we searched for a brain-organotropic metastatic signature, as a promising source for the discovery of new biomarkers involved in brain metastatic progression. Of relevance, we identified VGF (nerve growth factor inducible) as a key mediator in this process, also impacting the BBB and microglial functions both in vitro and in vivo. In a series of human breast tumors, VGF was found to be expressed in both cancer cells and the adjacent stroma. Importantly, VGF-positive tumors showed a significantly worse prognosis and were associated with HER2 (human epidermal growth factor receptor 2) overexpression and triple-negative molecular signatures. Further clinical validation in primary tumors from metastatic BC cases showed a significant association between VGF and the brain metastatic location, clearly and significantly impacting on the prognosis of BC patients with brain metastasis. In conclusion, our study reveals a unique secretome signature for BC with a tropism for the brain, highlighting VGF as a crucial mediator in this process. Furthermore, its specific impact as a poor prognostic predictor for BC patients with brain metastasis opens new avenues to target VGF to control the progression of brain metastatic disease. © 2024 The Pathological Society of Great Britain and Ireland.

Keywords: VGF; blood–brain barrier; brain pre‐metastatic niche; brain signature; breast cancer brain metastasis; microglia; prognostic biomarker.

PubMed Disclaimer

References

    1. Lin NU, Bellon JR, Winer EP. CNS metastases in breast cancer. J Clin Oncol 2004; 22: 3608–3617.
    1. Liu Q, Zhang H, Jiang X, et al. Factors involved in cancer metastasis: a better understanding to “seed and soil” hypothesis. Mol Cancer 2017; 16: 176.
    1. Chen W, Hoffmann AD, Liu H, et al. Organotropism: new insights into molecular mechanisms of breast cancer metastasis. NPJ Precis Oncol 2018; 2: 4.
    1. Obenauf AC, Massagué J. Surviving at a distance: organ‐specific metastasis. Trends Cancer 2015; 1: 76–91.
    1. Müller A, Homey B, Soto H, et al. Involvement of chemokine receptors in breast cancer metastasis. Nature 2001; 410: 50–56.

Publication types

Substances